Sign in
4

Changes in Ownership

REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000122

Director sold 10,838 shares at an average $1,158.17 ($12,552,285)

  • Director acquired 10,838 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

POON CHRISTINE A · Director

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-15 Exercise or conversion : show line 1 in the form +10,838 $413.33 $4,479,671 13,010 D
2024-08-15 Sale : show line 2 in the form −1,012 $1,155.72 $1,169,589 11,998 D
2024-08-15 Sale : show line 3 in the form −2,368 $1,156.30 $2,738,118 9,630 D
2024-08-15 Sale : show line 4 in the form −1,560 $1,157.33 $1,805,435 8,070 D
2024-08-15 Sale : show line 5 in the form −212 $1,158.02 $245,500 7,858 D
2024-08-15 Sale : show line 6 in the form −5,352 $1,159.56 $6,205,965 2,506 D
2024-08-15 Sale : show line 7 in the form −234 $1,160.45 $271,545 2,272 D
2024-08-15 Sale : show line 8 in the form −100 $1,161.32 $116,132 2,172 D
Open-market sales · 10,838 sh · avg $1,158.17 · $12,552,285

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-08-15 Exercise or conversion : show line 9 in the form Non-Qualified Stock Option (right to buy) −10,838 0 D
Loading xslF345X05/edgardoc.xml…